Objectives
rheumatoid arthritis, RA-ILD
RHEUMATOID ARTHRITIS, INTERSTITIAL LUNG DISEASE, PULMONARY FIBROSIS
Some patients with rheumatoid arthritis develop interstitial lung disease (RA-ILD) that develops into progressive pulmonary fibrosis. We assessed the efficacy and safety of nintedanib versus placebo in patients with progressive RA-ILD in the INBUILD trial.